Can we use API to wean tMCS? Michele Esposito and colleagues explore this possibility in Journal of Cardiac Failure manuscript. Jeffrey Yourshaw Anthony Carnicelli, MD FACC Mark Belkin Jon Grinstein MD Molly Silkowski, DO Brian Houston MD MUSC Cardiology Fellowship Programs

HFStats.org is here! When you need key #heartfailure statistics for presentations, research, or social media discussions, turn to HF Stats. The graphics, slides, fact sheets, and infographics feature data derived from the annual HF Stats report in Journal of Cardiac Failure. They’re

We are proud to announce the first patient enrollment today at Saint Luke's Mid America Heart Institute for the fourth and final clinical trial (FINALITY-HF) of the larger MOONRAKER program on finerenone in heart failure. FINEARTS-HF, the first in the finerenone program,

#ACCMedStudent #ACCMedRes #ACCFIT Submit a challenging case in which invasive hemodynamic assessment was key to accurate diagnosis and/or management of a patient for free with a complimentary registration!!! Immediately before #AHA24 Mark Belkin Ryan J Tedford MD Jon Grinstein MD

🔥 Now in Circ: HF🔥 Acute hemodynamic effect of pacing in HM3 patients (HURRY-LVAD) - prospective, invasive hemo study of HM3 pts w ppm - main findings: ⬆️ pacing rate ➡️ worsening RV hemos, ⬆️ PAWP, and no change in CO/CI ahajournals.org/doi/10.1161/CI…

Check out our editorial on the FAIR-HFpEF trial in EHJ!! Thanks to my incredible mentor Robert Mentz, MD for the opportunity to work on this! European Society of Cardiology Journals Duke Clinical Research Institute Duke Cardiology Fellows

🔥off the press: our piece on PH due to Left Heart Disease from the 7th WSPH. Lots of new ideas: disaggregating subtypes, new staging system, trial design & recent trial outcomes. bit.ly/4fc5p1V Montani David #BradMaron Vallerie McLaughlin teresa De Marco Jean-Luc Vachiery 🫀

So proud of IHF fellow Molly Silkowski, DO & Alec Biscopink & Ryan Moore for their work on API in shock! 8yrs after Navin Kapur showed me the ropes at my 1st ACURE, I’m honored to pass the torch! More to come! Ryan J Tedford MD A-CURE Working Group MUSC Cardiology Fellowship Programs

API for the LV and PAPI for the RV reflect ventricular efficiency and ventricular coupling. Augmentation of API with LV unloading reflects a ventricle that was able to recouple, regain more favorable energetics promoting the path to recovery. Ryan J Tedford MD Stavros George Drakos

More data showing the association of API with CV outcomes, now in TGA patients with systemic RVs Great work by Nael Althweib leading this team to this important publication on hemodynamics in this ACHD population! Circ: Heart Failure

Mechanistic Differences between Torsemide and Furosemide Prospective data debunks classic teachings 🔵No meaningful PK/PD advantages for T 🔵Kidney bioavailability less w T 🔵Ratio T:F was 4:1 (not 2:1!) 🔵T w ⬆️neurohormonal activ & kidney dysfunction journals.lww.com/jasn/abstract/…

Dynamic Assessment of LV Coupling & Myocardial Reserve in Cardiogenic Shock - API & CPO after milrinone drug study improved risk stratification in SCAI Stage C CS pts and outcomes (e.g. LVAD, OHT, or death) at 1 year. Jon Grinstein MD Mark Belkin #EHJOpen academic.oup.com/ehjopen/advanc…

Presented at #ESC2024 and published in @JACC. #CSWG's next contribution to #waronshock by Khue Ton Elric Zweck Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Jacob Abraham, MD Song Li A. Reshad Garan MD Jaime Hernandez-Montfort Serial Shock Severity Assessment Within 72 Hours After Diagnosis jacc.org/doi/10.1016/j.…

#ESCCongress Exciting results from VAD WEAN Cardiac Recovery International Registry (>750 pts, >50 sites): a) multi-year durability of cardiac recovery equivalent to post-Transplant survival b) similarly favorable results for all HF etiologies. Wilfried Mullens Harriette Van Spall, MD MPH

#Finerenone in #HeartFailure and Chronic Kidney Disease with T2DM The #FINEHEARTS-HF pooled analysis of cardiovascular, kidney, and mortality outcomes The three trials #FIDELIO-DKD, #FIGARO-DKD, and #FINEARTS-HF; 📍18,991 participants studied over a median of 2.9 years. 📍CV

🔥 fresh SoA review 🔥 JACC Journals To supplement discussion of #MRA European Society of Cardiology News European Society of Cardiology We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.

#ESCCongress 2024, London, UK Can we identify who are the advanced HF patients that can recover their hearts ? Can we use a practical personalized tool to guide our recommendations for our patients’ therapeutic options: LVAD as bridge to recovery Vs. direct heart Tx or other ?

Interesting hemodynamic case in the UChicago #cathlab this week with Orly Leiva, MD. There was consistent return of RA waveform on expiration and we confirmed no PAC migration under fluoro. What do you think is going on here?

📣OUT NOW Despite #GDMTworks, your patient with HF is still symptomatic & at high risk for adverse outcomes; now what 🤔? Explore the full range of device-based therapies for #FunctionNotFailure in the latest HFSA Scientific Statement in @jcardfail! 🔗 bit.ly/47pAL1l

Journal of Cardiac Failure is proud to publish this comprehensive Scientific Statement on Devices in #FunctionNotFailure led by Marat Fudim, MD MHS Jerry Estep & others. Check it out! 🔗 bit.ly/47pAL1l